Navigation Links
Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
Date:6/22/2013

arge cardiovascular outcome trial.

About Diabetes
Approximately 25.8 million Americans2 and an estimated 371 million people worldwide3 have type 1 or type 2 diabetes. T2D is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.2 Diabetes is a chronic condition that occurs when the body does not properly produce or use the hormone insulin4. Diabetes was estimated to cost the U.S. $245 billion in direct medical costs and reduced productivity in 2012.5

Boehringer Ingelheim and Eli Lilly and Company
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on three compounds representing several of the largest diabetes treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of people with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned co
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
2. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
3. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
4. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
7. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
8. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
11. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 Thousands of people will peacefully ... the opioid addiction epidemic at dozens of rallies across ... 2008, the United States has ... prescription opioids and heroin, yet the President has never ... worded letter to President Obama , rally organizers ...
(Date:8/31/2015)... ALBANY, New York , August 31, 2015 ... Research report states that the global cardiovascular monitoring ... in 2012 and is predicted to reach a ... at a CAGR of 9.7% between 2013 and ... Monitoring and Diagnostic Devices Market (ECG, Holter Monitors, ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015  The departments ... an event today at Gaudenzia Concept 90 to raise ... drug overdose crisis in Pennsylvania ... treatment and focus on recovery through the Building ... many Pennsylvanians are dying every day to a disease ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... MOUNTAIN VIEW, Calif., Aug. 12 As more and more ... spinal surgery techniques, the negatives of the spinal fusion market ... five years, the industry expects to see a steady inflow ... in the market. (Logo:   http://www.medicaldevices.frost.com ), ...
... Nev., Aug. 13 PDL BioPharma, Inc. (PDL) (Nasdaq: ... and the PDL BioPharma logo are considered trademarks of ... This press release contains forward-looking statements. Each ... results may differ materially from those, express or implied, ...
Cached Medicine Technology:Frost & Sullivan: Innovative Products and Technologies Strengthen U.S. Spinal Surgery Market 2PDL BioPharma Receives Letter from Genentech Relating to European Patents 2
(Date:9/1/2015)... ... 01, 2015 , ... CanAm Enterprises LLC, (“CanAm”) is pleased ... cards (I-829 petition approval) from the USCIS through an investment in one of ... the EB-5 visa process for immigrant investors to become lawful permanent residents of ...
(Date:9/1/2015)... ... 01, 2015 , ... The PracticeMatch Career Fair ... the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, IN 46225. More than ... the country. All specialties will be represented. Attendees will enjoy free hors d’oeuvres ...
(Date:9/1/2015)... Aventura, Florida (PRWEB) , ... September 01, 2015 ... ... across language barriers and international borders seldom arise at the most convenient time ... which is always ready to help. , Universal Translation Services has ...
(Date:9/1/2015)... Las Vegas, NV (PRWEB) , ... September 01, ... ... home care or Self-Directed Care is, how to access caregivers and what to ... of other valuable and pertinent information. , Founded in 2006 in Canoga Park, ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It is the first-ever, ... dedicated to the provision of quality addiction treatment and the utilization of ...
Breaking Medicine News(10 mins):Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:MAP Health Management Launches the MAP Recovery Network 2
... ... Prodigy® meters throughout Europe , ... Charlotte, N.C. (Vocus) September 30, 2009 -- Prodigy® brand blood glucose monitoring systems will now ... Mark. , , , , ,Prodigy Diabetes Care, LLC, is an affiliate of Diagnostic Devices, ...
... Ann Taylor Stores Corporation (NYSE: ANN ) reaffirmed ... the Company supports through its ,ANN Cares,® and ,LOFT Cares,(TM) ... Month in October, the Company is proud to support The ... sale of ,ANN Cares,® and ,LOFT Cares,(TM) Cards. Through ...
... injury that happened to USC football player, Stafon Johnson was ... the weight room to add to a long list of ... the University of Arizona revealed that 980,000 injuries occurred in ... injuries to specific body parts, as follows: Hand 23.1%, Upper ...
... But mortality still higher among black women than white women, ... Fewer women in the United States are dying from breast ... and blacks, a new report shows. , Deaths from breast ... 1990. And in the past decade that decline in deaths ...
... Technologies Holding Group Inc. (Pink Sheets: CTYX), announced today that ... independent registered public accountant for the purpose of becoming a ... and preparation for filing Form 10 with the SEC. ... to become a Fully Reporting Company in 2010. , ...
... Wash., Sept. 30 Edifecs, Inc., the proven ... it is providing a free Commercial-Off-The-Shelf (COTS) solution ... for Medicare & Medicaid Services (CMS) requirements for ... Edifecs, third free software offering (after the Edifecs5010(TM) ...
Cached Medicine News:Health News:Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 2Health News:Ann Taylor Supports The Fight Against Breast Cancer 2Health News:Sport Science Lab Maintains That Injury to USC Football Player is Symptomatic of the Dangers of Conventional Weight Training 2Health News:Breast Cancer Death Rates Continue to Drop 2% Annually 2Health News:Breast Cancer Death Rates Continue to Drop 2% Annually 3Health News:Connectyx Technologies Retained the Marcum Group in New York as its Independent Registered Public Accountant for the Purpose of Becoming a Fully Reporting Company 2Health News:Edifecs(TM) Provides Free Commercial-Off-The-Shelf (COTS) Solution for Medicare Administrative Contractors (MACs) 2
... Mammography has been FDA approved, and represents ... It is the first and only mammography ... - the highest available. SenoScan's larger field ... breast support is more comfortable and helps ...
... P3000 heralds a new concept in pupillometry, designed ... optical system developed for the P2000. We ... which we have paid particular attention to the ... new system is extremely flexible, allowing you to ...
... most useful features is the PupilFit software ... analysis of the pupil images, producing accurate, ... The fitted circle is shown as a ... that the measurement ismeaningful, and not just ...
... urine analyzer that ensures accurate results, test ... by reducing "hands on" operator time. And ... ideal fit for work areas large or ... is designed for continuous sample processing of ...
Medicine Products: